Novel approaches to pediatric vaccine delivery

被引:28
作者
O'Hagan, DT
Rappuoli, R
机构
[1] Chiron Vaccines, Oakland, CA 94608 USA
[2] Chiron Vaccines, I-53100 Siena, Italy
关键词
vaccine delivery; vaccine adjuvants; needle-free immunization; topical immunization;
D O I
10.1016/j.addr.2005.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although currently available vaccines represent an outstanding success story in modem medicine and have had a dramatic effect on morbidity and mortality worldwide, it is clear that improvements in vaccine delivery are required. Vaccine delivery improvements may include the addition of novel injectable adjuvants, or the use of novel routes of delivery, including mucosal immunization. Mucosal delivery may be required to provide protection against pathogens that infect at mucosal sites, including sexually transmitted diseases. Alternatively, novel approaches to delivery, including mucosal administration, may be used to improve compliance for existing vaccines. Of particular interest for safer mass immunization are needle-free delivery devices, which would avoid problems due to needle re-use in many parts of the world, or needle-stick injuries. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 51
页数:23
相关论文
共 163 条
[71]   Induction of protective immunity against lethal anthrax challenge with a patch [J].
Kenney, RT ;
Yu, JM ;
Guebre-Xabier, M ;
Frech, SA ;
Lambert, A ;
Heller, BA ;
Ellingsworth, LR ;
Eyles, JE ;
Williamson, ED ;
Glenn, GM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (04) :774-782
[72]   Dose sparing with intradermal injection of influenza vaccine [J].
Kenney, RT ;
Frech, SA ;
Muenz, LR ;
Villar, CP ;
Glenn, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (22) :2295-2301
[73]  
KENNEY RT, 2003, EXPERT REV VACCINES, V2
[74]   EFFICIENT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS ANTIGEN UPON PHAGOCYTOSIS BY MACROPHAGES [J].
KOVACSOVICSBANKOWSKI, M ;
CLARK, K ;
BENACERRAF, B ;
ROCK, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :4942-4946
[75]   Low-dose intradermal administration of recombinant hepatitis B vaccine in children:: 5-year follow-up study [J].
Kurugöl, Z ;
Erensoy, S ;
Aksit, S ;
Egemen, A ;
Bilgiç, A .
VACCINE, 2001, 19 (28-29) :3936-3939
[76]   A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects [J].
Lambert, JS ;
Keefer, M ;
Mulligan, MJ ;
Schwartz, D ;
Mestecky, J ;
Weinhold, K ;
Smith, C ;
Hsieh, R ;
Moldoveanu, Z ;
Fast, P ;
Forrest, B ;
Koff, W .
VACCINE, 2001, 19 (23-24) :3033-3042
[77]   Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers [J].
Le, TP ;
Coonan, KM ;
Hedstrom, RC ;
Charoenvit, Y ;
Sedegah, M ;
Epstein, JE ;
Kumar, S ;
Wang, RB ;
Doolan, DL ;
Maguire, JD ;
Parker, SE ;
Hobart, P ;
Norman, J ;
Hoffman, SL .
VACCINE, 2000, 18 (18) :1893-1901
[78]   Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice [J].
Luo, YP ;
O'Hagan, D ;
Zhou, H ;
Singh, M ;
Ulmer, J ;
Reisfeld, RA ;
Primus, FJ ;
Xiang, R .
VACCINE, 2003, 21 (17-18) :1938-1947
[79]   Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application [J].
Maa, YF ;
Zhao, L ;
Payne, LG ;
Chen, DX .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) :319-332
[80]  
MALOY KJ, 1994, IMMUNOLOGY, V81, P661